Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 3, 2025

November 3, 2025

Lightweight multi-wavelength network model for efficient and high-fidelity full-color 3D holographic display

EIN Presswire

November 3, 2025

Single-emitter white OLEDs could cut costs and chemicals in next generation lighting

EIN Presswire

November 3, 2025

Dr. John Zielonka Completes National Spinal Decompression Certification Program Among World’s Leading Spine Experts

EIN Presswire

November 3, 2025

First Patient Treated with BioVentrix® Revivent System in RELIVE Trial at Saint Luke’s Mid America Heart Institute

EIN Presswire

$Chinese Neurosurgical Journal Study Redefines Refractory Hydrocephalus for Better Care$

November 3, 2025

Chinese Neurosurgical Journal Study Redefines Refractory Hydrocephalus for Better Care

EIN Presswire

November 3, 2025

Ecer.com Drives B2B Trade Intelligence with AI-Powered Engine

EIN Presswire

November 3, 2025

Dr. Kenneth Rosenfield Joins Salus Scientific Scientific & Advocacy Advisory Board

EIN Presswire

November 3, 2025

Will Bitcoin Drop Below $100K? Volatility Is Unpredictable — AG META RWA Shows You How to Hedge Risks with Real Assets

GlobeNewswire

November 3, 2025

Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

November 3, 2025

Krown Network & Quantum eMotion Launch Qastle; The First Hot Wallet Secured by Quantum Entropy & Post-Quantum Encryption

EIN Presswire

November 3, 2025

FDA Approves KYGEVVI® (doxecitine and doxribtimine), the First and Only Treatment for Adults and Children Living with Thymidine Kinase 2 deficiency (TK2d), a Rare and Devastating Mitochondrial Disease

GlobeNewswire

November 3, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

November 3, 2025

Flo Health and Dr. Sameena Rahman Address Perimenopause and Its Workplace Impact with YourUpdateTV

GlobeNewswire

November 3, 2025

Datavault AI, Music Dash and NFHITS Partner to Transform Music Data Tracking Display and Monetization Through Patented Inaudible Tones®, AI and Blockchain Technology

GlobeNewswire

November 3, 2025

Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

GlobeNewswire

November 3, 2025

DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer

GlobeNewswire

November 3, 2025

DBV Technologies annonce la nomination de Kevin Trapp, dirigeant chevronné du secteur, au poste de Directeur Commercial

GlobeNewswire

November 3, 2025

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

November 3, 2025

Chiesi Global Rare Diseases and Protalix BioTherapeutics Seek Re-examination from the EMA for the Negative Opinion for Elfabrio (pegunigalsidase alfa) Alternative Dosing Regimen of Every Four Weeks in the EU

GlobeNewswire

November 3, 2025

HII Names Tim Taylor as Vice President of Engineering, Technology, and Design at Newport News Shipbuilding

GlobeNewswire